Investors are still interested in short squeeze stocks, and we’ve got them covered with the ones to watch this week!
Fintel is offering up a list of the short squeeze stocks to watch with its Short Squeeze Leaderboard. The publication takes into account several factors when including shares on its list. Among these are relative short interest, borrow fee rates, trading volume and more.
Fintel uses a grading system ranging from zero to 100 when making its Short Squeeze Leaderboard. The closer a stock is to 100, the more likely it is to undergo a short squeeze.
Keeping all of that in mind, let’s take a look at the top five short squeeze stocks traders need to keep an eye on!
Top 5 Short Squeeze Stocks to Watch This Week
- Greenwich Lifesciences (NASDAQ:GLSI) stock starts off the list with a short squeeze score of 96.58.
- Blue Apron (NYSE:APRN) shares claim the second spot on the list with a short squeeze score of 96.46.
- Surge (NASDAQ:SURG) stock is up next with the company’s shares earnings a short squeeze score of 95.88.
- Syros Pharmaceuticals (NASDAQ:SYRS) shares claim the next position on the list with a short squeeze score of 95.25.
- TDH (NASDAQ:PETZ) stock takes the final spot on the list with a short squeeze score of 95.16.
Investors looking for more stock market news today are in the right place!
InvestorPlace has traders covered with our deep dives into the stock market. For Monday, that includes what’s going on with shares of Norwegian Cruise Line (NYSE:NCLH), APRN stock and LogicBio (NASDAQ:LOGC) shares. You can read up on all these topics at the following links!
More Monday Stock Market News
- NCLH Stock Alert: What to Know as Norwegian Cruise Line Drops Covid-19 Precautions
- Blue Apron (APRN) Stock Falls 33% on CFO Departure, Stock Sale
- Why Is LogicBio (LOGC) Stock Up 600% Today?
On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com Publishing Guidelines.
